KaliVir Immunotherapeutics’ Licensing Agreement With Astellas Pharma Inc.

Fenwick & West LLP advised KaliVir Immunotherapeutics on the deal. KaliVir Immunotherapeutics, an early stage biotech company developing cutting-edge, next-generation oncolytic viral immunotherapy programs, in its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here